flagtherapeutics.com
FLAG THERAPEUTICS to Present at NYC Oncology Conference
FLAG’s President and Chief Executive Officer (CEO) Frank Sorgi, Ph.D., will discuss FLAG’s two platforms and its application in orphan oncology, specifically glioblastoma multiforme (GBM).